L3Harris Technologies Total Adjusted Segment Operating Income by Year

L3Harris Technologies Total Adjusted Segment Operating Income: $3,451M in FY2025, up 4.8% from a year earlier.

“|| Supplemental Recast Information || Full Year || 2025 | 2024 || (In millions) | Revenue | Operating Income | Operating Margin | Revenue | Operating Income | Operating Margin || || SMS | $ | 10,711 | $ | 1,055 | 9.8 | % | $ | 10,186 | $ | 1,046 | 10.3 | % || CSD | 7,566 | 1,924 | 25.4 | % | 7,272 | 1,670 | 23.0 | % || MSL 1 | 3,797 | 364 | 9.6 | % | 3,525 | 405 | 11.5 | % || Other non-reportable businesses 2 | 146 | 23 | 15.8 | % | 711 | 148 | 20.8 | % || Segment operating income and margin | 3,366 | 15.4 | % | 3,269 | 15.3 | % || Segment impairment of goodwill and other assets 3 | 85 | 24 || Adjusted segment operating income and margin | 3,451 | 15.8 | % | 3,293 | 15.4 | %”

Source: LHX Q4 & FY2025 Earnings Release (Ex. 99.1) (filed 2026-01-29) ↗

Consolidated operating income before unallocated corporate department expenses and segment goodwill impairments.

• Adjusted Segment Operating Margin (%)15.8% · FY2025
• Total Unallocated Corporate Department Expenses1,233 · FY2025
• Unallocated Corporate — LHX NeXt Transformation & Implementation Costs167 · FY2025
• Unallocated Corporate — Amortization of Acquisition-Related Intangibles769 · FY2025
• Unallocated Corporate — M&A and Divestiture Transaction Expenses57 · FY2025
• Unallocated Corporate — Business Divestiture Losses/(Gains) & Impairments82 · FY2025
• Consolidated Company-Funded R&D Expense535 · FY2025
• Company-Funded R&D as % of Consolidated Revenue2.5% · FY2025

See every metric in the L3Harris Technologies KPI table. Data updated Nov 3, 2026.